Literature DB >> 19160043

Risk factors for gastrointestinal ulcer disease in the US population.

Donald Garrow1, Mark H Delegge.   

Abstract

PURPOSE: Gastrointestinal (GI) ulcers are frequently seen in patients with multiple chronic medical conditions. Few studies have described the overall prevalence, comorbidities, or risk factors associated with this diagnosis. We sought to determine among a national dataset if individuals with certain medical comorbidities are at increased risk for gastrointestinal ulcer disease, while controlling for relevant confounders.
RESULTS: The overall prevalence of GI ulcer is 8.4%. A significant increased risk of ulcer history is associated with older age (OR 1.67), African-Americans (OR 1.20) current (OR 1.99) and former (OR 1.55) tobacco use, former alcohol use (OR 1.29), obesity (OR 1.18), chronic obstructive pulmonary disease (OR 2.34), chronic renal insufficiency (OR 2.29), coronary heart disease (OR 1.46), and three or more doctor visits in a year (OR 1.49).
CONCLUSIONS: This large US population-based study reports on a number of demographic, behavioral, and chronic medical conditions associated with higher risk of gastrointestinal ulcer disease.

Entities:  

Mesh:

Year:  2009        PMID: 19160043     DOI: 10.1007/s10620-008-0708-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  7 in total

1.  Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus.

Authors:  H H Xia; N J Talley; E P Kam; L J Young; J Hammer; M Horowitz
Journal:  Am J Gastroenterol       Date:  2001-04       Impact factor: 10.864

2.  Diabetes mellitus and operated peptic ulcer disease.

Authors:  J M Duggan; E A O'Keefe; A L Weaver; A R Zinsmeister; L J Melton
Journal:  J Gastroenterol Hepatol       Date:  1992 May-Jun       Impact factor: 4.029

3.  Association of Helicobacter pylori infection with coronary heart disease.

Authors:  P Pieniazek; E Karczewska; A Duda; W Tracz; M Pasowicz; S J Konturek
Journal:  J Physiol Pharmacol       Date:  1999-12       Impact factor: 3.011

4.  Health impact of peptic ulcer in the United States.

Authors:  A Sonnenberg; J E Everhart
Journal:  Am J Gastroenterol       Date:  1997-04       Impact factor: 10.864

5.  Histamine, xanthine oxidase generated oxygen-derived free radicals and Helicobacter pylori in gastroduodenal inflammation and ulceration.

Authors:  A Ben-Hamida; W K Man; N McNeil; J Spencer
Journal:  Inflamm Res       Date:  1998-04       Impact factor: 4.575

6.  Involvement of free radicals and histamine in the potentiating action of cigarette smoke exposure on ethanol-induced gastric mucosal damage in rats.

Authors:  J Y Chow; L Ma; C H Cho
Journal:  Free Radic Biol Med       Date:  1998-05       Impact factor: 7.376

7.  [Association of chronic obstructive bronchitis and upper digestive pathology. A clinical study].

Authors:  G Caruso; D Catalano; N Scalisi; S Terranova; C Virgilio; O Mazzone
Journal:  Recenti Prog Med       Date:  1991-11
  7 in total
  21 in total

1.  A retrospective observation on 105 patients with chronic cluster headache receiving indomethacin.

Authors:  Anaé Monta; Sylvain Redon; Cyprien Fabre; Anne Donnet
Journal:  Neurol Sci       Date:  2021-02-05       Impact factor: 3.307

2.  Weekly pattern of emergency room admissions for peptic ulcers: a population-based study.

Authors:  Li-Ting Kao; Ming-Chieh Tsai; Herng-Ching Lin; Femi Pai; Cha-Ze Lee
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

3.  The dynamic of nasogastric decompression after esophagectomy and its predictive value of postoperative complications.

Authors:  Yan Zhao; Jie Guo; Bin You; Shengcai Hou; Bin Hu; Hui Li
Journal:  J Thorac Dis       Date:  2016-02       Impact factor: 2.895

4.  Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis.

Authors:  Shunsuke Yamamoto; Kenji Watabe; Shusaku Tsutsui; Shinichi Kiso; Toshimitsu Hamasaki; Motohiko Kato; Yoshihiro Kamada; Yuichi Yoshida; Shinji Kihara; Miyuki Umeda; Aiko Furubayashi; Kazuo Kinoshita; Osamu Kishida; Takashi Fujimoto; Akira Yamada; Yoshifumi Tsukamoto; Norio Hayashi; Yuji Matsuzawa
Journal:  Dig Dis Sci       Date:  2011-03-30       Impact factor: 3.199

5.  Different peptic ulcer bleeding risk in chronic kidney disease and end-stage renal disease patients receiving different dialysis.

Authors:  Kuang-Wei Huang; Hsin-Bang Leu; Jiing-Chyuan Luo; Wan-Leong Chan; Ming-Chih Hou; Han-Chieh Lin; Fa-Yauh Lee; Yi-Chun Kuan
Journal:  Dig Dis Sci       Date:  2013-12-08       Impact factor: 3.199

6.  Protective effects of Dialium guineense pulp on aspirin-induced gastric mucosal injury in albino rats.

Authors:  Nwogo Ajuka Obasi; Chinyere Aloke; Stella Eberechukwu Obasi; Chinedu Ogbonnia Egwu; Ademola Clement Famurewa; Patience Nkemjika Ogbu
Journal:  J Appl Biomed       Date:  2021-06-10       Impact factor: 1.797

7.  Discovery of Novel Small-Molecule FAK Activators Promoting Mucosal Healing.

Authors:  Qinggang Wang; Ricardo Gallardo-Macias; Mikhail Y Golovko; Ahmed Adham Raafat Elsayed; Shyam K More; Sema Oncel; Vadim J Gurvich; Marc D Basson
Journal:  ACS Med Chem Lett       Date:  2021-02-16       Impact factor: 4.345

8.  Therapeutic Endoscopy in Combination with Quadruple Therapy in Treating Bleeding Caused by Gastric Ulcer.

Authors:  Yuqin Zuo; Shuhui Wang; Xiujuan Cui; Hongna Lv
Journal:  Pak J Med Sci       Date:  2018 Jan-Feb       Impact factor: 1.088

9.  Fast Eating Speed Increases the Risk of Endoscopic Erosive Gastritis in Korean Adults.

Authors:  Min-Kyung Kim; Byung Joon Ko; E-Yeon Kim; Byoung-Duck Han; Kyung-Hwan Cho
Journal:  Korean J Fam Med       Date:  2015-11-20

10.  Peptic ulcer disease risk in chronic kidney disease: ten-year incidence, ulcer location, and ulcerogenic effect of medications.

Authors:  Chih-Chia Liang; Chih-Hsin Muo; I-Kuan Wang; Chiz-Tzung Chang; Che-Yi Chou; Jiung-Hsiun Liu; Tzung-Hai Yen; Chiu-Ching Huang; Chi-Jung Chung
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.